Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial

Drug and Alcohol Dependence

Volumn 161, Issue , 2016, Pages 119-126

  Murphy, Sean M ^a   Campbell, Aimee N C ^b   Ghitza, Udi E ^c   Kyle, Tiffany L ^d   Bailey, Genie L ^e,f   Nunes, Edward V ^b   Polsky, Daniel ^g  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d Aspire Health Partners   (United States)

^e BROWN UNIVERSITY   (United States)

^f Stanley Street Treatment and Resources ^*  (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Community reinforcement approach; Contingency management; Cost effectiveness; Internet based intervention; Substance use disorders

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; OPIATE;

ADULT; ARTICLE; COMMUNITY REINFORCEMENT APPROACH; CONTINGENCY MANAGEMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTERNET; INTERNET BASED INTERVENTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; THERAPEUTIC EDUCATION SYSTEM; TREATMENT OUTCOME; BEHAVIOR THERAPY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; PROCEDURES; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ADULT; BEHAVIOR THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; INTERNET; MALE; QUALITY-ADJUSTED LIFE YEARS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84957627686     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.01.021     Document Type: Article

References (42)

1. Albright J., Ciaverelli R., Essex A., Tkacz J., Ruetsch C. Psychiatrist characteristics that influence use of buprenorphine medication-assisted treatment. J. Addict. Med. 2010, 4:197-203.
2. Bewick B.M., Trusler K., Barkham M., Hill A.J., Cahill J., Mulhern B. The effectiveness of web-based interventions designed to decrease alcohol consumption-a systematic review. Prev. Med. 2008, 47:17-26.
3. Bickel W.K., Amass L., Higgins S.T., Badger G.J., Esch R.A. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J. Consult. Clin. Psychol. 1997, 65:803.
4. Bickel W.K., Marsch L.A., Buchhalter A.R., Badger G.J. Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial. Exp. Clin. Pharmacol. 2008, 6:132.
5. Bouchery E.E., Harwood H.J., Sacks J.J., Simon C.J., Brewer R.D. Economic costs of excessive alcohol consumption in the U.S., 2006. Am. J. Prev. Med. 2011, 41:516-524.
6. Budney A.J. Therapy Manuals For Drug Addiction: A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction 1998, U.S. Department of Health and Human Services, National Institute on Drug Abuse, Washington.
7. Bureau of Labor Statistics, 2014. Occupational Outlook Handbook, Bureau of Labor Statistics, . http://www.bls.gov/ooh/home.htm.
8. Campbell A.N., Nunes E.V., Miele G.M., Matthews A., Polsky D., Ghitza U.E., Turrigiano E., Bailey G.L., VanVeldhuisen P., Chapdelaine R. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp. Clin. Trials 2012, 33:386-395.
9. Campbell A.N., Nunes E.V., Matthews A.G., Stitzer M., Miele G.M., Polsky D., Turrigiano E., Walters S., McClure E.A., Kyle T.L., Wahle A., Van Veldhuisen P., Goldman B., Babcock D., Stabile P.Q., Winhusen T., Ghitza U.E. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. Am. J. Psychiatry 2014, 171:683-690.
10. Cunningham C.O., Kunins H.V., Roose R.J., Elam R.T., Sohler N.L. Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. J. Gen. Intern. Med. 2007, 22:1325-1329.
11. Dolan P. Modeling valuations for EuroQol health states. Med. Care 1997, 35:1095-1108.
12. French M.T. Drug Abuse Treatment Cost Anslysis Program (DATCAP): User's Manual 2003, University of Miami, Florida.
13. Garcia-Rodriguez O., Secades-Villa R., Higgins S.T., Fernandez-Hermida J.R., Carballo J.L., Errasti Perez J.M., Diaz S.A.-h. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial. Exp. Clin. Psychopharmacol. 2009, 17:131.
14. Glick H., Doshi J.A., Sonnad S.S., Polsky D. Economic Evaluation In Clinical Trials 2007, University Press, Oxford.
15. Gunderson E.W., Fiellin D.A., Levin F.R., Sullivan L.E., Kleber H.D. Evaluation of a combined online and in person training in the use of buprenorphine. Subst. Abuse 2006, 27:39-45.
16. Higgins S.T., Budney A.J., Bickel W.K., Foerg F.E., Donham R., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatry 1994, 51:568-576.
17. Higgins S.T., Sigmon S.C., Wong C.J., Heil S.H., Badger G.J., Donham R., Dantona R.L., Anthony S. Community reinforcement therapy for cocaine-dependent outpatients. Arch. Gen. Psychiatry 2003, 60:1043-1052.
18. Hirth R.A., Chernew M.E., Miller E., Fendrick A.M., Weissert W.G. Willingness to pay for a quality-adjusted life year: in search of a standard. Med. Decis. Making 2000, 20:332-342.
19. Kvamme E., Catlin M., Banta-Green C., Roll J., Rosenblatt R. Who prescribes buprenorphine for rural patients? The impact of specialty, location and practice type in Washington State. J. Subst. Abuse Treat. 2013, 44:355-360.
20. Manning W.G., Mullahy J. Estimating log models: to transform or not to transform?. J. Health Econ. 2001, 20:461-494.
21. Mark T.L., Kranzler H.R., Poole V.H., Hagen C.A., McLeod C., Crosse S. Barriers to the use of medications to treat alcoholism. Am. J. Addict. 2003, 12:281-294.
22. Mark T.L., Kranzler H.R., Song X., Bransberger P., Poole V.H., Crosse S. Physicians' opinions about medications to treat alcoholism. Addiction 2003, 98:617-626.
23. Moore B.A., Fazzino T., Garnet B., Cutter C.J., Barry D.T. Computer-based interventions for drug use disorders: a systematic review. J. Subst. Abuse Treat. 2011, 40:215-223.
24. Murphy S.M., Fishman P.A., McPherson S., Dyck D.G., Roll J.R. Determinants of buprenorphine treatment for opioid dependence. J. Subst. Abuse Treat. 2014, 46:315-319.
25. Murphy S.M., McDonell M.G., McPherson S., Srebnik D., Angelo F., Roll J.M., Ries R.K. An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness. Drug Alcohol Depend. 2015, 153:293-299.
26. Murray E., Burns J., See T.S., Lai R., Nazareth I. Interactive Health Communication Applications for people with chronic disease. Cochrane Database Syst. Rev. 2005, 4.
27. National Drug Intelligence Center The Economic Impact Of Illicit Drug Use On American Society 2011, United States Department of Justice, Washington, D.C.
28. Olmstead T.A., Petry N.M. The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine-or opioid-dependent outpatients. Drug Alcohol Depend. 2009, 102:108-115.
29. Park R.E. Estimation with heteroscedastic error terms. Econometrica 1966, 34:888.
30. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., Obert J., Killeen T., Saladin M.E., Cowell M., Kirby K.C., Sterling R., Royer-Malvestuto C., Hamilton J., Booth R.E., Macdonald M., Liebert M., Rader L., Burns R., DiMaria J., Copersino M., Stabile P.Q., Kolodner K., Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch. Gen. Psychiatry 2005, 62:1148-1156.
31. Polsky D., Glick H.A., Yang J., Subramaniam G.A., Poole S.A., Woody G.E. Cost-effectiveness of extended buprenorphine-naloxone treatment for opioid-dependent youth: data from a randomized trial. Addiction 2010, 105:1616-1624.
32. Raven M.C., Carrier E.R., Lee J., Billings J.C., Marr M., Gourevitch M.N. Substance use treatment barriers for patients with frequent hospital admissions. J. Subst. Abuse Treat. 2010, 38:22-30.
33. Seaman S.R., White I.R. Review of inverse probability weighting for dealing with missing data. Stat. Methods Med. Res. 2013, 22:278-295.
34. Sindelar J.L., Olmstead T.A., Peirce J.M. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007, 102:1463-1471.
35. Spek V., Cuijpers P., Nyklícek I., Riper H., Keyzer J., Pop V. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol. Med. 2007, 37:319-328.
36. Stitzer M.L., Petry N.M., Peirce J. Motivational incentives research in the national drug abuse treatment clinical trials network. J. Subst. Abuse Treat. 2010, 38:S61-S69.
37. Substance Abuse and Mental Health Services Administration, 2014. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48. Substance Abuse and Mental Health Services Administration, Rockville, MD.
38. Substance Abuse and Mental Health Services Administration, 2013. National Survey of Substance Abuse Treatment Services (N-SSATS): 2012. Data on Substance Abuse Treatment Facilities. BHSIS Series S-66, HHS Publication No. (SMA) 14-4809. Rockville, MD.
39. Tate D.F., Finkelstein E.A., Khavjou O., Gustafson A. Cost effectiveness of internet interventions: review and recommendations. Ann. Behav. Med. 2009, 38:40-45.
40. The EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
41. Walley A.Y., Alperen J.K., Cheng D.M., Botticelli M., Castro-Donlan C., Samet J.H., Alford D.P. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J. Gen. Intern. Med. 2008, 23:1393-1398.
42. Wantland D.J., Portillo C.J., Holzemer W.L., Slaughter R., McGhee E.M. The effectiveness of Web-based vs: non-Web-based interventions: a meta-analysis of behavioral change outcomes. J. Med. Internet Res. 2004, 6:e40.